Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD

Respiratory Medicine

Volumn 108, Issue 1, 2014, Pages 122-128

  Leivo Korpela, Sirpa ^a,b   Lehtimäki, Lauri ^a,b   Vuolteenaho, Katriina ^b   Nieminen, Riina ^b   Kööbi, Lea ^a   Järvenpää, Ritva ^a   Kankaanranta, Hannu ^b,c   Saarelainen, Seppo ^a   Moilanen, Eeva ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c SEINÄJOKI CENTRAL HOSPITAL   (Finland)

Author keywords

Adipokines; Adiponectin; Chronic obstructive pulmonary disease (COPD); Glucocorticoid; Leptin; Pulmonary emphysema

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; FIXOTIDE DISKUS; FLUTICASONE PROPIONATE; GELATINASE B; GLUCOCORTICOID; INTERLEUKIN 6; LEPTIN; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; APPETITE; ARTICLE; BLOOD LEVEL; BODY PLETHYSMOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENERGY METABOLISM; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; HYPERINFLATION; INFLAMMATION; LUNG EMPHYSEMA; LUNG FUNCTION; MALE; METABOLIC REGULATION; MIDDLE AGED; PATHOGENESIS; PRIORITY JOURNAL; SMOKING; SMOOTH MUSCLE FIBER; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE;

ADIPOKINES; ADIPONECTIN; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD); GLUCOCORTICOID; LEPTIN; PULMONARY EMPHYSEMA;

ADIPONECTIN; ADIPOSE TISSUE; ADMINISTRATION, INHALATION; ANDROSTADIENES; BIOLOGICAL MARKERS; BRONCHODILATOR AGENTS; GLUCOCORTICOIDS; HUMANS; LEPTIN; MALE; PLETHYSMOGRAPHY, WHOLE BODY; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; SPIROMETRY; TREATMENT OUTCOME;

EID: 84893655972     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.08.016     Document Type: Article

References (59)

1. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, and P. Calverley et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
2. P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellular mechanisms Eur Respir J 22 2003 672 688
3. E.F. Wouters, N.L. Reynaert, M.A. Dentener, and J.H. Vernooy Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc Am Thoracic Soc 6 2009 638 647
4. A.G. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets Systemic effects of chronic obstructive pulmonary disease Eur Respir J 21 2003 347 360
5. L.M. Fabbri, and K.F. Rabe From COPD to chronic systemic inflammatory syndrome? Lancet 370 2007 797 799
6. P.J. Barnes, and B.R. Celli Systemic manifestations and comorbidities of COPD Eur Respir J 33 2009 1165 1185
7. D.D. Sin, P. Lacy, E. York, and S.F. Man Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 760 765
8. G. Fantuzzi Adipose tissue, adipokines, and inflammation J Allergy Clin Immunol 115 2005 911 919
9. Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, and J. Miyagawa et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83
10. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, and S. Kita et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769
11. H. Tilg, and A.R. Moschen Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nat Rev Immunol 6 2006 772 783
12. M. Miller, J.Y. Cho, A. Pham, J. Ramsdell, and D.H. Broide Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease J Immunol 182 2009 684 691
13. R. Lago, R. Gomez, M. Otero, F. Lago, R. Gallego, and C. Dieguez et al. A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes Osteoarthr Cartil 16 2008 1101 1109
14. R. Gomez, J. Conde, M. Scotece, J.J. Gomez-Reino, F. Lago, and O. Gualillo What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7 2011 528 536
15. A. Koskinen, S. Juslin, R. Nieminen, T. Moilanen, K. Vuolteenaho, and E. Moilanen Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways Arthritis Res Ther 13 2011 R184
16. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
17. N. Ouchi, J.L. Parker, J.J. Lugus, and K. Walsh Adipokines in inflammation and metabolic disease Nat Rev Immunol 11 2011 85 97
18. G.M. Lord, G. Matarese, J.K. Howard, R.J. Baker, S.R. Bloom, and R.I. Lechler Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression Nature 394 1998 897 901
19. J. Santos-Alvarez, R. Goberna, and V. Sanchez-Margalet Human leptin stimulates proliferation and activation of human circulating monocytes Cell Immunol 194 1999 6 11
20. A. Koskinen, K. Vuolteenaho, R. Nieminen, T. Moilanen, and E. Moilanen Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients Clin Exp Rheumatol 29 2011 57 64
21. M. Maffei, H. Fei, G.H. Lee, C. Dani, P. Leroy, and Y. Zhang et al. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus Proc Natl Acad Sci U S A 92 1995 6957 6960
22. M. Scotece, J. Conde, R. Gomez, V. Lopez, J. Pino, and A. Gonzalez et al. Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases Mediators Inflamm 2012 2012 125458
23. A. Bruno, P. Chanez, G. Chiappara, L. Siena, S. Giammanco, and M. Gjomarkaj et al. Does leptin play a cytokine-like role within the airways of COPD patients? Eur Respir J 26 2005 398 405
24. J.H. Vernooy, N.E. Drummen, R.J. van Suylen, R.H. Cloots, G.M. Moller, and K.R. Bracke et al. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers Thorax 64 2009 26 32
25. N. Ali Assad, and A. Sood Leptin, adiponectin and pulmonary diseases Biochimie 94 2012 2180 2189
26. J.H. Shin, J.H. Kim, W.Y. Lee, and J.Y. Shim The expression of adiponectin receptors and the effects of adiponectin and leptin on airway smooth muscle cells Yonsei Med J 49 2008 804 810
27. S. Leivo-Korpela, L. Lehtimaki, R. Nieminen, P. Oksa, T. Vierikko, and R. Jarvenpaa et al. Adipokine adipsin is associated with the degree of lung fibrosis in asbestos-exposed workers Respir Med 106 2012 1435 1440
28. R. Sauni, P. Oksa, L. Lehtimaki, P. Toivio, P. Palmroos, and R. Nieminen et al. Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers Occup Environ Med 69 2012 256 260
29. S.R. Desai, D.M. Hansell, A. Walker, S.L. MacDonald, F. Chabat, and A.U. Wells Quantification of emphysema: a composite physiologic index derived from CT estimation of disease extent Eur Radiol 17 2007 911 918
30. I. Orlandi, C. Moroni, G. Camiciottoli, M. Bartolucci, M. Pistolesi, and N. Villari et al. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation Radiology 234 2005 604 610
31. J. Conde, M. Scotece, R. Gomez, V. Lopez, J.J. Gomez-Reino, and F. Lago et al. Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity Biofactors 37 2011 413 420
32. A. Sood Obesity, adipokines, and lung disease J Appl Physiol 108 2010 744 753
33. S. Leivo-Korpela, L. Lehtimäki, K. Vuolteenaho, R. Nieminen, H. Kankaanranta, and S. Saarelainen et al. Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma J Inflamm (Lond) 8 2011 12
34. M.K. Breyer, E.P. Rutten, N.W. Locantore, M.L. Watkins, B.E. Miller, and E.F. Wouters ECLIPSE investigators (evaluation of COPD longitudinally to identify predictive surrogate endpoints). Dysregulated adipokine metabolism in chronic obstructive pulmonary disease Eur J Clin Investig 42 2012 983 991
35. K. Tomoda, M. Yoshikawa, T. Itoh, S. Tamaki, A. Fukuoka, and K. Komeda et al. Elevated circulating plasma adiponectin in underweight patients with COPD Chest 132 2007 135 140
36. S. Kirdar, M. Serter, E. Ceylan, A.G. Sener, T. Kavak, and F. Karadag Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease Scand J Clin Lab Investig 69 2009 219 224
37. K.H. Chan, S.C. Yeung, T.J. Yao, M.S. Ip, A.H. Cheung, and M.M. Chan-Yeung et al. Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease Int J Tuberc Lung Dis 14 2010 1193 1200
38. B.J. Carolan, Y.I. Kim, A.A. Williams, K. Kechris, S. Lutz, and N. Reisdorph et al. The association of adiponectin with CT phenotypes in chronic obstructive pulmonary disease Am J Respir Crit Care Med 2013
39. R. Pellegrino, G. Viegi, V. Brusasco, R.O. Crapo, F. Burgos, and R. Casaburi et al. Interpretative strategies for lung function tests Eur Respir J 26 2005 948 968
40. M. Ding, A.C. Carrao, R.J. Wagner, Y. Xie, Y. Jin, and E.M. Rzucidlo et al. Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype J Mol Cell Cardiol 52 2012 474 484
41. C. de Oliveira, A.B. de Mattos, C. Biz, L.M. Oyama, E.B. Ribeiro, and C.M. do Nascimento High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations Lipids Health Dis 10 2011 11
42. C. Jang, W.J. Inder, V.R. Obeyesekere, and F.P. Alford Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone Clin Endocrinol (Oxf) 69 2008 745 750
43. K.C. Lewandowski, K. Szosland, and A. Lewinski Short-term dexamethasone administration does not alter serum adiponectin or resistin concentrations in overweight and obese subjects despite an increase in insulin resistance Clin Endocrinol (Oxf) 65 2006 551 552
44. J.V. Patel, D.E. Cummings, J.P. Girod, A.V. Mascarenhas, E.A. Hughes, and M. Gupta et al. Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment J Negat Results Biomed 5 2006 14
45. S.F. Man, Z. Xuekui, R. Vessey, T. Walker, K. Lee, and D. Park et al. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study Therap Adv Respir Dis 3 2009 73 80
46. R. Summer, F.F. Little, N. Ouchi, Y. Takemura, T. Aprahamian, and D. Dwyer et al. Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice Am J Physiol Lung Cell Mol Physiol 294 2008 1035 1042
47. K. Nakanishi, Y. Takeda, S. Tetsumoto, T. Iwasaki, K. Tsujino, and H. Kuhara et al. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy Am J Respir Crit Care Med 183 2011 1164 1175
48. M. Miller, A. Pham, J.Y. Cho, P. Rosenthal, and D.H. Broide Adiponectin-deficient mice are protected against tobacco-induced inflammation and increased emphysema Am J Physiol Lung Cell Mol Physiol 299 2010 834 842
49. J.A. Dickens, B.E. Miller, L.D. Edwards, E.K. Silverman, D.A. Lomas, and R. Tal-Singer Evaluation of COPD longitudinally to identify surrogate endpoints (ECLIPSE) study investigators. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort Respir Res 12 2011 146
50. M.K. Breyer, E.P. Rutten, J.H. Vernooy, M.A. Spruit, M.A. Dentener, and C. van der Kallen et al. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin Respir Med 105 2011 1046 1053
51. N. Takabatake, H. Nakamura, S. Abe, T. Hino, H. Saito, and H. Yuki et al. Circulating leptin in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 159 1999 1215 1219
52. S. Eker, L. Ayaz, L. Tamer, and B. Ulubas Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease Scand J Clin Lab Investig 70 2010 40 44
53. F. Machinal-Quelin, M.N. Dieudonne, R. Pecquery, M.C. Leneveu, and Y. Giudicelli Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue Endocrine 18 2002 179 184
54. E.C. Creutzberg, E.F. Wouters, I.M. Vanderhoven-Augustin, M.A. Dentener, and A.M. Schols Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2000 1239 1245
55. G. Krommidas, K. Kostikas, G. Papatheodorou, A. Koutsokera, K.I. Gourgoulianis, and C. Roussos et al. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers Respir Med 104 2010 40 46
56. P. Nair, K. Radford, A. Fanat, L.J. Janssen, M. Peters-Golden, and P.G. Cox The effects of leptin on airway smooth muscle responses Am J Respir Cell Mol Biol 39 2008 475 481
57. S. Sukumaran, W.J. Jusko, D.C. DuBois, and R.R. Almon Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression J Pharmacol Exp Ther 337 2011 734 746
58. M.A. Cimmino, G. Andraghetti, L. Briatore, B. Salani, M. Parodi, and M. Cutolo et al. Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica Ann N Y Acad Sci 1193 2010 160 163
59. D.W. Gong, S. Bi, R.E. Pratley, and B.D. Weintraub Genomic structure and promoter analysis of the human obese gene J Biol Chem 271 1996 3971 3974